Analyze Diet
Veterinary ophthalmology2001; 3(2-3); 169-191; doi: 10.1046/j.1463-5224.2000.00119.x

The diagnosis and treatment of periorbital sarcoid in the horse: 445 cases from 1974 to 1999.

Abstract: OBJECTIVE: Diagnosis and management of periorbital sarcoids in horses is a significant clinical challenge for the practicing veterinary surgeon and pathologist. The purpose of this study was to investigate the response of various types of sarcoids to different therapeutic methods. Animals studied Medical records of 445 clinical patients. Procedures This paper retrospectively examines the clinical and histological features of periorbital sarcoids and the treatment of 445 cases. Treatment by surgical excision, cryosurgery, Bacillus-Calmette-Gaérin (BCG) immunomodulation, topical cytotoxic applications, and radiation are described. RESULTS: Six types of sarcoid can be found in the immediate periorbital region and each has some characteristics of other disorders of the skin with which they can be confused. The diagnosis of sarcoids is, however, relatively simple in most cases. The lesions are not necessarily restricted to the dermis and epidermis, but commonly invade into the subcutis and the deeper muscular structures around the eye. Treatment with radiation is expensive and difficult to manage but resulted in the best outcome with almost 100% resolution in 66 cases. By contrast, surgical excision has serious potential complications that arise primarily as a result of the infiltrative nature of periorbital sarcoids. The value of BCG immunomodulation therapy for fibroblastic and nodular lesions described by previous workers is confirmed in this paper, with a good overall response (69%), provided that the material was injected intralesionally. Perilesional injection did not appear to carry a significant benefit. However, treatment of verrucose or occult lesions by this method gave generally poor results. The results of intralesional injection of cisplatin emulsions suggest that this may be an effective method of treatment in cases where other modalities are not feasible. In common with previous reports, failure to resolve the lesions frequently resulted in regrowth of the tumor, and in most cases this recurrence appeared to be more aggressive, with extensive local infiltration and faster growth. Conclusion The periorbital tissues are less tolerant of damage than those at many other sites and therefore certain treatment methods may be contraindicated. This suggests that it is important to select the best possible treatment at the first opportunity. It is a wise precaution to warn owners of horses with periorbital sarcoids of the dangers of leaving them and the particular risks associated with the currently available treatments.
Publication Date: 2001-06-09 PubMed ID: 11397301DOI: 10.1046/j.1463-5224.2000.00119.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article examines the various ways to diagnose and treat periorbital sarcoids in horses, using a study of 445 clinical patients. They explore different therapeutic methods such as surgical excision, cryosurgery, Bacillus-Calmette-Gaérin (BCG) immunomodulation, topical cytotoxic applications, and radiation, concluding that radiation offers the best outcome, although it is expensive and hard to manage.

Studied Procedures

  • The article looks into the clinical and histological characteristics of periorbital sarcoids by retrospectively examining the cases of 445 horses.
  • Various treatments such as surgical removal, cryosurgery, Bacillus-Calmette-Gaérin (BCG) immunomodulation, topical cytotoxic applications, and radiation are investigated for their effectiveness.

Results of the Study

  • Research shows that sarcoids can take six different forms in the periorbital region and can often be mistaken for other skin disorders. However, sarcoids are relatively easy to diagnose in most cases.
  • Sarcoids are not only restricted to the layer immediately beneath the skin but can also invade the subcutaneous layer and the deeper muscle structures around the eye.
  • Radiation treatment, although costly and complicated, yielded the most successful results, with nearly a 100% resolution rate in 66 cases.
  • On the other hand, surgical removal could be problematic due to the potential complications that emerge mainly from the invasive nature of periorbital sarcoids.
  • BCG immunomodulation therapy, when injected directly into the sarcoid, has proven to be effective in treating fibroblastic and nodular lesions, with a 69% efficiency rate. However, the value of this therapy diminished when applied to treatment of verrucose or hidden lesions.
  • The study suggests the method of injecting cisplatin emulsions directly into the sarcoid might be beneficial where other methods are not feasible.

Conclusions of the Study

  • It is argued that, because periorbital tissues are less accepting of damage than tissues in other parts of the horse’s body, some treatment methods may not be appropriate.
  • It is strongly recommended to choose the most effective treatment, as failing to resolve the lesions often resulted in a more aggressive recurrence of the tumor – with quicker local infiltration and growth.
  • Horse owners are advised to be aware of the risks of leaving periorbital sarcoids untreated, as well as the potential dangers associated with current treatments.

Cite This Article

APA
Knottenbelt DC, Kelly DF. (2001). The diagnosis and treatment of periorbital sarcoid in the horse: 445 cases from 1974 to 1999. Vet Ophthalmol, 3(2-3), 169-191. https://doi.org/10.1046/j.1463-5224.2000.00119.x

Publication

ISSN: 1463-5224
NlmUniqueID: 100887377
Country: England
Language: English
Volume: 3
Issue: 2-3
Pages: 169-191

Researcher Affiliations

Knottenbelt, D.C.
  • Department of Veterinary Clinical Science and Animal Husbandry, University of Liverpool, Leahurst, Neston, Wirral, UK; Department of Veterinary Pathology, University of Liverpool, Leahurst, Neston, Wirral, UK.
Kelly, D.F.

    Citations

    This article has been cited 15 times.
    1. Jindra C, Hainisch EK, Brandt S. Immunotherapy of Equine Sarcoids-From Early Approaches to Innovative Vaccines. Vaccines (Basel) 2023 Mar 30;11(4).
      doi: 10.3390/vaccines11040769pubmed: 37112681google scholar: lookup
    2. Hamza E, Cosandey J, Gerber V, Koch C, Unger L. The potential of three whole blood microRNAs to predict outcome and monitor treatment response in sarcoid-bearing equids. Vet Res Commun 2023 Jan;47(1):87-98.
      doi: 10.1007/s11259-022-09930-7pubmed: 35484337google scholar: lookup
    3. Saba C, Eggleston R, Parks A, Peroni J, Sjoberg E, Rice S, Tyma J, Williams J, Grosenbaugh D, Leard AT. ALVAC-fIL2, a feline interleukin-2 immunomodulator, as a treatment for sarcoids in horses: A pilot study. J Vet Intern Med 2022 May;36(3):1179-1184.
      doi: 10.1111/jvim.16425pubmed: 35416353google scholar: lookup
    4. Cosandey J, Hamza E, Gerber V, Ramseyer A, Leeb T, Jagannathan V, Blaszczyk K, Unger L. Diagnostic and prognostic potential of eight whole blood microRNAs for equine sarcoid disease. PLoS One 2021;16(12):e0261076.
      doi: 10.1371/journal.pone.0261076pubmed: 34941894google scholar: lookup
    5. Unger L, Abril C, Gerber V, Jagannathan V, Koch C, Hamza E. Diagnostic potential of three serum microRNAs as biomarkers for equine sarcoid disease in horses and donkeys. J Vet Intern Med 2021 Jan;35(1):610-619.
      doi: 10.1111/jvim.16027pubmed: 33415768google scholar: lookup
    6. Giraldo A, Pinard CL, Plattner BL, Dubois MS. Periocular sarcoid with bone invasion in a Thoroughbred mare. Can Vet J 2020 Apr;61(4):415-419.
      pubmed: 32255829
    7. Byron CR, DeWitt MR, Latouche EL, Davalos RV, Robertson JL. Treatment of Infiltrative Superficial Tumors in Awake Standing Horses Using Novel High-Frequency Pulsed Electrical Fields. Front Vet Sci 2019;6:265.
      doi: 10.3389/fvets.2019.00265pubmed: 31475163google scholar: lookup
    8. Rizk A, Mosbah E, Karrouf G, Abou Alsoud M. Surgical Management of Penile and Preputial Neoplasms in Equine with Special Reference to Partial Phallectomy. J Vet Med 2013;2013:891413.
      doi: 10.1155/2013/891413pubmed: 26464915google scholar: lookup
    9. Mosseri S, Hetzel U, Hahn S, Michaloupoulou E, Sallabank HC, Knottenbelt DC, Kipar A. Equine sarcoid: In situ demonstration of matrix metalloproteinase expression. Vet J 2014 Nov;202(2):279-85.
      doi: 10.1016/j.tvjl.2014.07.026pubmed: 25439440google scholar: lookup
    10. Finlay M, Yuan Z, Morgan IM, Campo MS, Nasir L. Equine sarcoids: Bovine Papillomavirus type 1 transformed fibroblasts are sensitive to cisplatin and UVB induced apoptosis and show aberrant expression of p53. Vet Res 2012 Dec 4;43(1):81.
      doi: 10.1186/1297-9716-43-81pubmed: 23210796google scholar: lookup
    11. Yuan ZQ, Nicolson L, Marchetti B, Gault EA, Campo MS, Nasir L. Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts. J Virol 2008 Jul;82(13):6481-91.
      doi: 10.1128/JVI.00429-08pubmed: 18434409google scholar: lookup
    12. Monteiro MM, de Castro ELA, Pereira AJM, Thiesen R, Thiesen RMC, Salvarani FM. BCG Immunotherapy in Equine Sarcoid Treatment: Mechanisms, Clinical Efficacy, and Challenges in Veterinary Oncology. Viruses 2025 Sep 29;17(10).
      doi: 10.3390/v17101322pubmed: 41157593google scholar: lookup
    13. Smith CH, Stewart HL, Stefanovski D, Levine DG. Outcomes following autologous tumor tissue implantation with or without concurrent antineoplastic therapies in the treatment of sarcoids in 50 equids. Front Vet Sci 2025;12:1559519.
      doi: 10.3389/fvets.2025.1559519pubmed: 40417356google scholar: lookup
    14. Labens R, Saba C, Williams J, Hollis A, Ensink J, Jose-Cunilleras E, Jordana-Garcia M, Bergvall K, Ruppin M, Condon F, Spelta C, Elce Y, De Ridder T, Morton J, McGee C, Reddell P. Intratumoural tigilanol tiglate in the multicentre treatment of equine sarcoids and cutaneous melanomas. Equine Vet J 2026 Jan;58(1):89-104.
      doi: 10.1111/evj.14502pubmed: 40170619google scholar: lookup
    15. Karalus W, Subharat S, Orbell G, Vaatstra B, Munday JS. Equine sarcoids: A clinicopathologic study of 49 cases, with mitotic count and clinical type predictive of recurrence. Vet Pathol 2024 May;61(3):357-365.
      doi: 10.1177/03009858231209408pubmed: 37937724google scholar: lookup